Back to glp
Directory

Semaglutide

53 documents

doc/longevity/glp/semaglutide
Semaglutide Ameliorates Osteoarthritis Progression Through a Weight Lossindepend2026.01.01
certainty: log·importance: 5/10
PDF11.2 MB
Discontinuation of Semaglutide Among Older Adults With Diabetes in the Us and Ja2025.01.01
certainty: log·importance: 5/10
PDF95.69 KB
Oral Semaglutide and Cardiovascular Outcomes in Highrisk Type 2 Diabetes2025.01.01
certainty: log·importance: 5/10
PDF3.69 MB
3 (Wang, 2024)2024.01.01
certainty: log·importance: 5/10
PDF2.49 MB
Association of Semaglutide With Risk of Suicidal Ideation in a Realworld Cohort2024.01.01
certainty: log·importance: 5/10
PDF6.1 MB
Central Glucagonlike Peptide 1 Receptor Activation Inhibits Tolllike Receptor Ag2024.01.01
certainty: log·importance: 5/10
PDF1.33 MB
Dispensing of Glucagonlike Peptide1 Receptor Agonists to Adolescents and Young a2024.01.01
certainty: log·importance: 5/10
PDF101.02 KB
Does Liraglutide Alleviate Inflammation in Braindead Donors a Randomized Clinica2024.01.01
certainty: log·importance: 5/10
PDF214.12 KB
Effects of Semaglutide on Chronic Kidney Disease in Patients With Type 2 Diabete2024.01.01
certainty: log·importance: 5/10
PDF234.44 KB
Onceweekly Semaglutide in Persons With Obesity and Knee Osteoarthritis2024.01.01
certainty: log·importance: 5/10
PDF12.92 MB
2 (Seo, 2023)2023.01.01
certainty: log·importance: 5/10
PDF534.05 KB
A Revolution in Obesity Treatment2023.01.01
certainty: log·importance: 5/10
PDF96.14 KB
Appendix2023.01.01
certainty: log·importance: 5/10
PDF82.35 KB
Daily Oral Glp1 Receptor Agonist Orforglipron for Adults With Obesity2023.01.01
certainty: log·importance: 5/10
PDF188.4 KB
Efficacy and Safety of Coadministered Onceweekly Cagrilintide 24mg With Onceweek2023.01.01
certainty: log·importance: 5/10
PDF562.75 KB
Efficacy and Safety of Oncedaily Oral Semaglutide 25mg and 50mg Compared With 142023.01.01
certainty: log·importance: 5/10
PDF120.59 KB
Feasibility of Exenatide a Glp1r Agonist for Treating Cocaine Use Disorder a Cas2023.01.01
certainty: log·importance: 5/10
PDF238.58 KB
Oral Semaglutide 50mg Taken Once Per Day in Adults With Overweight or Obesity Oa2023.01.01
certainty: log·importance: 5/10
PDF151.62 KB
Semaglutide and Cancer a Systematic Review and Metaanalysis2023.01.01
certainty: log·importance: 5/10
PDF1.18 MB
Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes2023.01.01
certainty: log·importance: 5/10
PDF287.46 KB
Semaglutide in Early Type 1 Diabetes2023.01.01
certainty: log·importance: 5/10
PDF79.62 KB
Substantial Decrease in Alcohol Use Disorder Symptoms Secondary to Semaglutide T2023.01.01
certainty: log·importance: 5/10
PDF105.49 KB
Supplement Mmc12023.01.01
certainty: log·importance: 5/10
PDF1.24 MB
Dose Titration With the Glucagonlike Peptide1 Agonist Liraglutide Reduces Cue an2022.01.01
certainty: log·importance: 5/10
PDF766.98 KB
Effect of Weekly Subcutaneous Semaglutide Vs Daily Liraglutide on Body Weight in2022.01.01
certainty: log·importance: 5/10
PDF170.36 KB
Endpoints and Estimands Understanding Trials of Weightloss Drugs2022.01.01
certainty: log·importance: 5/10
PDF132.32 KB
Liraglutide Provides Cardioprotection Through the Recovery of Mitochondrial Dysf2022.01.01
certainty: log·importance: 5/10
PDF722.31 KB
Onceweekly Semaglutide in Adolescents With Obesity2022.01.01
certainty: log·importance: 5/10
PDF198.33 KB
Antiinterleukin21 Antibody and Liraglutide for the Preservation of Cell Function2021.01.01
certainty: log·importance: 5/10
PDF182.67 KB
Antiobesity Drug Discovery Advances and Challenges2021.01.01
certainty: log·importance: 5/10
PDF1009.79 KB
Effect of Subcutaneous Semaglutide Vs Placebo as an Adjunct to Intensive Behavio2021.01.01
certainty: log·importance: 5/10
PDF151.99 KB
Healthy Weight Loss Maintenance With Exercise Liraglutide or Both Combined2021.01.01
certainty: log·importance: 5/10
PDF212.74 KB
Onceweekly Cagrilintide for Weight Management in People With Overweight and Obes2021.01.01
certainty: log·importance: 5/10
PDF148.92 KB
Onceweekly Semaglutide in Adults With Overweight or Obesity2021.01.01
certainty: log·importance: 5/10
PDF181.45 KB
Safety Tolerability Pharmacokinetics and Pharmacodynamics of Concomitant Adminis2021.01.01
certainty: log·importance: 5/10
PDF153.79 KB
Semaglutide 24mg Once a Week in Adults With Overweight or Obesity and Type 2 Dia2021.01.01
certainty: log·importance: 5/10
PDF155.7 KB
Glp1r Agonists for the Treatment of Obesity a Patent Review 2015present2020.01.01
certainty: log·importance: 5/10
PDF487.94 KB
Semaglutide 24mg for the Treatment of Obesity Key Elements of the Step Trials 1 2020.01.01
certainty: log·importance: 5/10
PDF467.19 KB
2 (Aroda, 2019)2019.01.01
certainty: log·importance: 5/10
PDF281.22 KB
Comparative Efficacy Safety and Cardiovascular Outcomes With Onceweekly Subcutan2019.01.01
certainty: log·importance: 5/10
PDF908.88 KB
Management of Endocrine Disease Are All Glp1 Agonists Equal in the Treatment of 2019.01.01
certainty: log·importance: 5/10
PDF557.43 KB
Oral Semaglutide Versus Subcutaneous Liraglutide and Placebo in Type 2 Diabetes 2019.01.01
certainty: log·importance: 5/10
PDF123.8 KB
2 (Peterson, 2018)2018.01.01
certainty: log·importance: 5/10
PDF873.68 KB
Efficacy and Safety of Semaglutide Compared With Liraglutide and Placebo for Wei2018.01.01
certainty: log·importance: 5/10
PDF129.69 KB
Semaglutide Versus Dulaglutide Once Weekly in Patients With Type 2 Diabetes Sust2018.01.01
certainty: log·importance: 5/10
PDF122.07 KB
Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on2017.01.01
certainty: log·importance: 5/10
PDF161.66 KB
Effects of Liraglutide on Weight Satiation and Gastric Functions in Obesity a Ra2017.01.01
certainty: log·importance: 5/10
PDF137.94 KB
Effects of Onceweekly Semaglutide on Appetite Energy Intake Control of Eating Fo2017.01.01
certainty: log·importance: 5/10
PDF786.12 KB
A Phase 2 Randomized Dosefinding Study of the Novel Onceweekly Human Glp1 Analog2016.01.01
certainty: log·importance: 5/10
PDF547.24 KB
Neurobehavioral Effects of Liraglutide and Sitagliptin in Experimental Models2016.01.01
certainty: log·importance: 5/10
PDF1.33 MB
Discovery of the Onceweekly Glucagonlike Peptide1 Glp1 Analogue Semaglutide2015.01.01
certainty: log·importance: 5/10
PDF521.27 KB
Glucagonlike Peptide1 Glp1 Receptor Agonist Prevents Development of Tolerance to2014.01.01
certainty: log·importance: 5/10
PDF764.11 KB
An Overview of Onceweekly Glucagonlike Peptide1 Receptor Agonistsavailable Effic2011.01.01
certainty: log·importance: 5/10
PDF195.14 KB
in Naperville, IL
Last visitor from Mitaka, Japan